Mitigation of T-cell dependent immunogenicity by reengineering factor VIIa analogue.
2019-09-09

2019. Jankowski W, McGill J, Lagassé HAD, Surov S, Bembridge G, Bunce C, Cloake E, Fogg MH, Jankowska KI, Khan A, Marcotrigiano J, Ovanesov MV, Sauna ZE. Blood Advances 3(17): 2668-2678.